Advances in Molecular Analysis of Fragile X Syndrome
552, Warren,W.T.&Nelson,D.L.JAMA 271:536-553, 1994
Duchenne Muscular Dystrophy
BMJ 368:L7012, Fox, H.,et al, 2020
Clinical and Mutational Spectrum of Neurofibromatosis Type 1-Like Syndrome
JAMA 302:2111-2118, 2150, 2170, Messian,L.,et al, 2009
Infant Developmental Milestones and Subsequent Cognitive Function
Ann Neurol 62:128-136, Murray,G.K.,et al, 2007
Learning Disability
Lancet 362:811-821, Gillberg,C.&Soderstrom,H., 2003
Cognitive and Motor Outcomes of Cocaine-Exposed Infants
JAMA 287:1952-1960,1990, Singer,L.T.,et al, 2002
Cognitive Function and Academic Performance in Neurofibromatosis 1:North
K. N. , et al, Neurol 48:1121-11277., , 1997
Adverse Outcomes of Bacterial meningitis in School-Age Survivors
Pediatrics 95:646-655, Grimwood,K.,et al, 1995
Neurofibromatosis Type 1:The Cognitive Phenotype
J Pediatr 124:S1-S8, Hofman,K.J.,et al, 1994
Specific Learning Disability in Children with Neurofibromatosis Type 1:Significance of MRI Abnormalities
Neurol 44:878-883, North,K.,et al, 1994
Course and Outcome of Acute Cerebellar Ataxia
Ann Neurol 35:673-679, Connolly,A.M.,et al, 1994
Learning & Memory Diff After Environ Exp to Waterways Cont Toxin-Producing Pfiesteria/Pfiesteria-Like Dinoflagellates
Lancet 352:532-539, Grattan,L.M.,et al, 1998
Attention-Deficit Hyperactivity Disorder in Adults
Clinical Therapeutics 14:138-147, Bellak,L.&Black,R.B., 1992